XVIVO Perfusion AB's (publ) board of directors announced that CEO Dag Andersson has suddenly passed away. The board has decided that Christoffer Rosenblad, currently vice president at XVIVO, will take over as acting CEO until a successor has been appointed.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
393 SEK | -0.76% | +2.75% | +19.12% |
Apr. 24 | Nordic Shares Declined Wednesday; Svenska Handelsbnkn Ser A Fell Furthest | DJ |
Apr. 24 | Transcript : Xvivo Perfusion AB, Q1 2024 Earnings Call, Apr 24, 2024 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+19.12% | 1.17B | |
-4.72% | 182B | |
+3.96% | 114B | |
-2.93% | 68.38B | |
+6.30% | 52.46B | |
+8.02% | 44.25B | |
+7.52% | 43.55B | |
+26.18% | 32.69B | |
+17.85% | 26.73B | |
+0.57% | 25.79B |
- Stock Market
- Equities
- XVIVO Stock
- News Xvivo Perfusion AB
- Xvivo Perfusion AB Announces CEO Changes